Does MELOXICAM Cause Focal segmental glomerulosclerosis? 16 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Focal segmental glomerulosclerosis have been filed in association with MELOXICAM (Meloxicam). This represents 0.2% of all adverse event reports for MELOXICAM.
16
Reports of Focal segmental glomerulosclerosis with MELOXICAM
0.2%
of all MELOXICAM reports
0
Deaths
4
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From MELOXICAM?
Of the 16 reports, 4 (25.0%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MELOXICAM. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does MELOXICAM Cause?
Drug ineffective (1,815)
Arthralgia (819)
Drug hypersensitivity (776)
Pain (709)
Pain in extremity (603)
Joint swelling (566)
Peripheral swelling (557)
Dizziness (542)
Fatigue (532)
Nausea (527)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which MELOXICAM Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
MELOXICAM vs MELPERONE
MELOXICAM vs MELPHALAN
MELOXICAM vs MEMANTINE
MELOXICAM vs MENINGOCOCCAL GROUP B VACCINE
MELOXICAM vs MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN